Seniors' adverse drug reactions need better prevention strategies
August 29, 2011 By Steve Tokar in MedicationsMedical practitioners need to implement new strategies for decreasing adverse drugs reactions among seniors, conclude the authors of a scientific literature review led by Michael Steinman, MD, a physician and geriatrics researcher at the San Francisco VA Medical Center.
Most approaches to preventing adverse drug events in older people have focused on getting doctors to prescribe the right drug in the first place, said Steinman. But, it turns out that the majority of adverse drug reactions occur because medications that are prescribed correctly sometimes have side effects.
Steinman, who is also an associate professor of medicine at the University of California, San Francisco, noted that approximately 10 percent of hospitalizations in older people are due to medication reactions, and that about one third of older adults have an adverse drug event every year.
The key to reducing adverse drug events, he said, is for doctors to focus not only on the initial decision of what to prescribe, but on finding ways to better catch and manage these adverse events soon after they occur, and before they can spiral out of control something that physicians have not always been very good at doing, Steinman said.
The review appears in the August 2011 issue of the Journal of the American Geriatrics Society.
One reason adverse medication reactions cause so much preventable harm, said Steinman, is that patients and physicians sometimes have difficulty recognizing those reactions. A patient might feel lightheaded or dizzy, or have an upset stomach or trouble thinking clearly, he said. Instead of recognizing those as drug side effects, we can end up on wild goose chases, looking for other diseases or conditions that could be causing those symptoms.
A common scenario, Steinman said, is one in which a patient gets stomach pains from a medication. Instead of stopping the drug, he said, the doctor prescribes a second drug for the stomach pains. That drug has a side effect, and the doctor gives a third drug to treat the side effects of the second drug, and so on.
The authors recommend several steps to help doctors better evaluate and manage drug side effects.
One step would be to design, or re-design, health information technology such as electronic medical records to monitor for possible side effects by cross-checking patients prescriptions, laboratory information and reported symptoms.
A second step would be to educate patients in how to recognize and report side effects, and to increase vigilance among medical professionals in checking for side effects in their patients. This requires us to actively follow up with patients, said Steinman. It doesnt have to be doctors who do this; pharmacists, nurses and even automated voice response systems over the telephone could provide early warning and advance notice.
A third step would be for medical schools to teach clinicians a more active approach to prescribing drugs and following up with patients. They note that interdisciplinary training can help physicians, pharmacists, nurses and other health professionals learn how to work together in ongoing assessments of patient care.
Provided by
University of California, San Francisco
-
Frailty not a factor in adverse drug reactions among seniors, study finds
Apr 07, 2011 |
not rated yet |
0
-
Doctor’s office is usually first stop in medication mishaps
May 06, 2011 |
not rated yet |
0
-
Everyday medicines can destroy lives, conference warns
Jul 07, 2011 |
not rated yet |
0
-
Genetic-screening trial could reduce drug side-effects
Jun 24, 2011 |
not rated yet |
0
-
Researchers still searching for ways to help patients take their meds
May 13, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
16 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Medications
May 24, 2012 |
not rated yet |
4
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Medications
May 23, 2012 |
not rated yet |
2
|
Patients may receive too much acetaminophen in hospital
(HealthDay) -- Roughly 2.5 percent of admitted hospital patients may receive more than the safe daily cumulative dose of the pain-reliever acetaminophen, best known as Tylenol, on at least one day, according ...
Medications
May 23, 2012 |
1 / 5 (1) |
0
New quality standards limiting elemental impurities in medicines announced
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters Elemental ImpuritiesLimits and ...
Medications
May 23, 2012 |
not rated yet |
0
Quality standards for heparin further strengthened
To help further secure a safe supply of the widelyused blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel ...
Medications
May 23, 2012 |
not rated yet |
0
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...